Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


FDA: Zofran 32-mg Dose Pulled From Market
The anti-nausea drug may cause serious heart problems at that dosage
This article is older than one year and is no longer available.

Copyright © 2012 HealthDay. All rights reserved.

May 6, 2015

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

Digoxin Tied to Higher Mortality Risk in A-Fib, Heart Failure

Experimental Drug Combo Shows Success in HCV Treatment

Risk of All Cancers, Specific Cancers Up in Infertile Men

Statins Linked to Improved Survival in Lung Cancer

Five 'Top Issues' to Be Discussed at AMA Medical Student Forum

Concussion in Football Often Occurs During Practice